252 related articles for article (PubMed ID: 6235448)
1. Mechanism of loss of natural killer activity in P815 ascites tumor bearing DBA/2 mice.
Saxena RK; Saxena QB; Adler WH
Nat Immun Cell Growth Regul; 1983-1984; 3(1):34-42. PubMed ID: 6235448
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of decline of natural killer cell activity in Corynebacterium parvum-treated mice: inhibition by erythroblasts and Thy 1.2+ lymphocytes.
Savary CA; Lotzová E
J Natl Cancer Inst; 1987 Sep; 79(3):533-41. PubMed ID: 2887687
[TBL] [Abstract][Full Text] [Related]
3. Analysis of natural killer effector and suppressor activity by intraepithelial lymphocytes from mouse small intestine.
Mowat AM; Tait RC; MacKenzie S; Davies MD; Parrott DM
Clin Exp Immunol; 1983 Apr; 52(1):191-8. PubMed ID: 6222852
[TBL] [Abstract][Full Text] [Related]
4. Population dynamics of natural killer cells and T lymphocytes in murine spleen and bone marrow during the development of erythroleukemia: the effect of indomethacin.
Miller SC; Christopher FL; Dussault I
Nat Immun; 1992; 11(2):78-91. PubMed ID: 1498521
[TBL] [Abstract][Full Text] [Related]
5. Natural killer activity in (C57BL/6 X DBA/2)F1 hybrids undergoing acute and chronic graft-vs.-host reaction.
Pattengale PK; Ramstedt U; Gidlund M; Orn A; Axberg I; Wigzell H
Eur J Immunol; 1983 Nov; 13(11):912-9. PubMed ID: 6641788
[TBL] [Abstract][Full Text] [Related]
6. Effects of adriamycin on the activity of mouse natural killer cells.
Santoni A; Riccardi C; Sorci V; Herberman RB
J Immunol; 1980 May; 124(5):2329-35. PubMed ID: 6444969
[TBL] [Abstract][Full Text] [Related]
7. Analysis of low natural killer cell activity in 89Sr-treated mice.
Mellen PF; Lust JA; Bennett M; Kumar V
Eur J Immunol; 1982 May; 12(5):442-5. PubMed ID: 6212259
[TBL] [Abstract][Full Text] [Related]
8. NK activity in carrageenan-treated mice.
Quan PC; Kolb JP; Lespinats G
Immunology; 1980 Aug; 40(4):495-503. PubMed ID: 6159311
[TBL] [Abstract][Full Text] [Related]
9. Modification of host antitumor defense mechanisms in mice by progressively growing tumor.
Maccubbin DL; Mace KF; Ehrke MJ; Mihich E
Cancer Res; 1989 Aug; 49(15):4216-24. PubMed ID: 2525950
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cells inhibit the development of autoantibody production in (C57BL/6 x DBA/2) F1 hybrid mice injected with DBA/2 spleen cells.
Harada M; Lin T; Kurosawa S; Maeda T; Umesue M; Itoh O; Matsuzaki G; Nomoto K
Cell Immunol; 1995 Mar; 161(1):42-9. PubMed ID: 7867084
[TBL] [Abstract][Full Text] [Related]
11. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
Genovesi EV; Pettey CL; Collins JJ
Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407
[TBL] [Abstract][Full Text] [Related]
12. Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens.
Bear HD
Cancer Res; 1986 Apr; 46(4 Pt 1):1805-12. PubMed ID: 2936451
[TBL] [Abstract][Full Text] [Related]
13. Gamma delta T cells in the pathobiology of murine acute graft-versus-host disease. Evidence that gamma delta T cells mediate natural killer-like cytotoxicity in the host and that elimination of these cells from donors significantly reduces mortality.
Ellison CA; MacDonald GC; Rector ES; Gartner JG
J Immunol; 1995 Nov; 155(9):4189-98. PubMed ID: 7594574
[TBL] [Abstract][Full Text] [Related]
14. A functional comparison of tumor cell killing by activated macrophages and natural killer cells.
Roder JC; Lohmann-Matthes ML; Domzig W; Kiessling R; Haller O
Eur J Immunol; 1979 Apr; 9(4):283-8. PubMed ID: 467492
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of natural killer cell numbers but not function in leukemic infant mice: a system primed in infancy allows survival in adulthood.
Dussault I; Miller SC
Nat Immun; 1993; 12(2):66-78. PubMed ID: 8318817
[TBL] [Abstract][Full Text] [Related]
16. In vivo modulation of thymus-derived lymphocytes with monoclonal antibodies in mice. III. Spontaneous and natural cytotoxic effector cells.
Herbert AG; Le Gros GS; Bidawid S; Watson JD
Immunology; 1984 Feb; 51(2):377-85. PubMed ID: 6607213
[TBL] [Abstract][Full Text] [Related]
17. NK cells from mammary tumor bearing mice do not exert natural killer activity but function as antibody dependent cellular cytotoxicity effectors.
Rivera LM; Lopez DM
Anticancer Res; 1993; 13(1):177-84. PubMed ID: 8476211
[TBL] [Abstract][Full Text] [Related]
18. Suppression of natural killer cell activity in infant mice occurs after target cell binding.
Dussault I; Miller SC
Nat Immun; 1995; 14(1):35-43. PubMed ID: 7599460
[TBL] [Abstract][Full Text] [Related]
19. Adoptive transfer of spleen cells from mice treated with radioactive strontium: suppressor cells, natural killer cells, and "hybrid resistance" in recipient mice.
Levy EM; Bennett M; Kumar V; Fitzgerald P; Cooperband SR
J Immunol; 1980 Feb; 124(2):611-8. PubMed ID: 6444313
[No Abstract] [Full Text] [Related]
20. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
